Merck & Co. MRK Total debt

Total debt at other companies

Bristol-Myers SquibbBMY

$43.33B-12.3%

PfizerPFE

$64.43B+4.9%

Johnson & JohnsonJNJ

$49.04B-3.4%

Regeneron PharmaceuticalsREGN

$2.71B+0.1%

CytokineticsCYTK

$418.21M+75.8%

Phibro Animal HealthPAHC

$32.25M+27.8%

FAQ

What is Merck & Co.'s total debt?

Merck & Co. (MRK) reported total debt of $49.1B in Q1 2026.

How has Merck & Co.'s total debt changed year-over-year?

Merck & Co.'s total debt increased by 35.8% year-over-year, from $36.16B to $49.1B.

What is the long-term trend for Merck & Co.'s total debt?

Over 5 years (2020 to 2025), Merck & Co.'s total debt has grown at a 8.1% compound annual growth rate (CAGR), from $35.73B to $52.8B.

What does total debt mean?

Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.